Kaleido BioSciences

Kaleido Biosciences Focuses on the Development of Microbiome-Related Drugs. Kaleido Biosciences has a broad product pipeline, with a few products already in early clinical development for rare genetic disorders, metabolic diseases, oncology, and opportunistic multidrug-resistant pathogens.